Gender differences in cardiovascular disease prevention

Menopause International

Volumn 14, Issue 1, 2008, Pages 13-17

  Jackson, Graham ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Coronary heart disease; Gender; Mortality; Prevention; Risk factors

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; ANGIOTENSIN II ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ORAL CONTRACEPTIVE AGENT; THIAZIDE DIURETIC AGENT;

ABDOMINAL OBESITY; ALCOHOL CONSUMPTION; CARDIOVASCULAR RISK; CAUSE OF DEATH; CLINICAL TRIAL; DIABETES MELLITUS; EXERCISE; FOOD INTAKE; FRUIT; HEALTH CARE PERSONNEL; HEART INFARCTION; HORMONAL THERAPY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; METABOLIC SYNDROME X; ORAL CONTRACEPTION; PRIMARY PREVENTION; REVIEW; SEX DIFFERENCE; SMOKING; VEGETABLE; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; FEMALE; MALE; MORTALITY; RISK FACTOR; RISK REDUCTION;

CARDIOVASCULAR DISEASES; CORONARY DISEASE; FEMALE; HUMANS; MALE; RISK FACTORS; RISK REDUCTION BEHAVIOR; SEX FACTORS;

EID: 47249110907     PISSN: 13621807     EISSN: 17404568     Source Type: Journal    
DOI: 10.1258/mi.2007.007031     Document Type: Review

References (26)

1. Bello N, Mosca L. Epidemiology of coronary heart disease in women. Prog Cardiovasc Dis 2004;46:287-295 (Pubitemid 38201291)
2. Stramba-Badiale M, Fox KM, Priori SG, et al. Cardiovascular disease in women: a statement from the policy conference of the European Society of Cardiology. Eur Heart J 2006;27:994-1005
3. Shaw K-T. Epidemiology of coronary heart disease in women. Heart 2006;92(Suppl. III):iii2-4
4. Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in US deaths from coronary disease, 1980-2000. N Engl J Med 2007;356:2388-2398
5. Mosca L, Banka CL, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation 2007;115:1481-1501
6. Mosca L, Mochari H, Christian A, et al. National study of women's awareness, preventive action and barriers to cardiovascular health. Circulation 2006;113:525-534 (Pubitemid 43754353)
7. Bolego C, Poli A, Paoletti R. Smoking and gender. Cardiovasc Res 2002;53:568-576
8. Califano JA. The wrong way to stay slim. N Engl J Med 1995;333:1214-1216
9. Allison DB, Fontaine KR, Manson JE, et al. Annual deaths attributable to obesity in the United States. JAMA 1999;282:1530-1538 (Pubitemid 29504046)
10. Collins P. Risk factors for cardiovascular disease and hormone therapy in women. Heart 2006;92(Suppl. III):iii24-8
11. Grundy SM. Obesity, metabolic syndrome and cardiovascular disease. J Clin Endocrinol Metab 2004;89:2595-2600 (Pubitemid 38766337)
12. Sesso HD, Paffenbarger RS, Ha T, et al. Physical activity and cardiovascular disease risk in middle-aged and older women. Am J Epidemiol 1999;150:408-416 (Pubitemid 29383489)
13. Manson JE, Greenland P, LaCroix AZ, et al. Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N Engl J Med 2002;347:716-722 (Pubitemid 35203902)
14. JBS2. Joint British Societies guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005;91(Suppl. V):v17-21
15. Williams B. Recent hypertension trials: implications and controversies. J Am Coll Cardiol 2005;45:813-827 (Pubitemid 40342804)
16. Nissen SE, Tuzcu EM, Libby P, et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure. The CAMELOT study: a randomised controlled trial. JAMA 2004;292:2217-2226
17. LaRosa JC, Hunninghake D, Bush D, et al. The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung and Blood Institute. The task force on cholesterol issues, American Heart Association. Circulation 1990;81:1721-1733
18. Khan R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal. Diab Care 2005;28:2289-2304
19. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. National Heart, Lung and Blood Institute. American Heart Association. Definition of metabolic syndrome: Report of the National Heart, Lung and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109:433-438
20. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Geneva: World Health Organization, 1999
21. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome (on line). See www.idf.org/webdata/docs/Metac- syndrome-def.pdf (accessed 1 October 2007)
22. Mendelsohn ME, Karas RH. HRT and the young at heart. N Engl J Med 2007;356:2639-2641
23. Manson JE, Allison MA, Roussouw JE, et al. Estrogen therapy and coronary artery calcification. N Engl J Med 2007;356:2591-2602 (Pubitemid 46961004)
24. Roberts H. Hormone replacement therapy comes full circle. BMJ 2007;335:219-220 (Pubitemid 47262409)
25. Ridker PM, Cook NR, Lee IM, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005;352:1293-1304 (Pubitemid 40411496)
26. Wilson BJ, Watson MS, Prescot GJ, et al. Hypertensive disease of pregnancy and risk of hypertension and stroke in later life: results from a cohort study. BMJ 2003;236:845-852 (Pubitemid 36461414)